These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 702337)

  • 1. Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.
    Smith SH; Harris LS; Uwaydah IM; Munson AE
    J Pharmacol Exp Ther; 1978 Oct; 207(1):165-70. PubMed ID: 702337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs of abuse and virus susceptibility.
    Friedman H; Klein T; Specter S; Pross S; Newton C; Blanchard DK; Widen R
    Adv Biochem Psychopharmacol; 1988; 44():125-37. PubMed ID: 2840802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testing the pharmacological activity of some synthetic cannabinoids in mice (author's transl)].
    Ganz AJ; Waser PG
    Arzneimittelforschung; 1980; 30(3):471-7. PubMed ID: 7387758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
    Hillard CJ; Harris RA; Bloom AS
    J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
    Shook JE; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the anti-enteroviral agent PTU-23 on immune response in normal mice.
    Marinova SP; Damjanova-Sarneva M; Galabov AS; Stoychkov JN
    Biomed Pharmacother; 1986; 40(1):33-6. PubMed ID: 3708117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo.
    Klein TW; Kawakami Y; Newton C; Friedman H
    J Toxicol Environ Health; 1991 Apr; 32(4):465-77. PubMed ID: 1850002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC).
    Klykken PC; Smith SH; Levy JA; Razdan R; Munson AE
    J Pharmacol Exp Ther; 1977 Jun; 201(3):573-9. PubMed ID: 864596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of immunological responses in mice by treatment with amphotericin B.
    Ferrante A; Rowan-Kelly B; Thong YH
    Clin Exp Immunol; 1979 Oct; 38(1):70-6. PubMed ID: 527256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids. I. Behavioral effects.
    Stark P; Dews PB
    J Pharmacol Exp Ther; 1980 Jul; 214(1):124-30. PubMed ID: 6771386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular effects of cannabinoids.
    Martin BR
    Pharmacol Rev; 1986 Mar; 38(1):45-74. PubMed ID: 2872689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
    Welch SP; Stevens DL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):10-8. PubMed ID: 1320680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP; Thomas C; Patrick GS
    J Pharmacol Exp Ther; 1995 Jan; 272(1):310-21. PubMed ID: 7815346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
    Artym J; Zimecki M; Kruzel ML
    Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol.
    Loveless SE; Harris LS; Munson AE
    J Immunopharmacol; 1981-1982; 3(3-4):371-83. PubMed ID: 6290570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
    Burstein S; Hunter SA; Ozman K
    Mol Pharmacol; 1983 Jan; 23(1):121-6. PubMed ID: 6865895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.